Cargando…

Efficacy and safety of polymyxin E sulfate in the treatment of critically ill patients with carbapenem-resistant organism infections

OBJECTIVE: Polymyxins are currently the last line of defense in the treatment of carbapenem-resistant organisms (CRO). As a kind of polymyxin available for clinical use in China, we aim to explore the efficacy and safety of colistin sulfate (Polymyxin E sulfate, PES) in this study. METHODS: This rea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Xin, Zhong, Cejun, Liu, Yanbin, Ye, Hui, Qu, Junyan, Zong, Zhiyong, Lv, Xiaoju
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834999/ https://www.ncbi.nlm.nih.gov/pubmed/36643845 http://dx.doi.org/10.3389/fmed.2022.1067548

Ejemplares similares

Polymyxin B/Tigecycline Combination vs. Polymyxin B or Tigecycline Alone for the Treatment of Hospital-Acquired Pneumonia Caused by Carbapenem-Resistant Enterobacteriaceae or Carbapenem-Resistant Acinetobacter baumannii
por: Chang, Kang, et al.
Publicado: (2022)

Clinical Efficacy of Polymyxin B in Patients Infected with Carbapenem-Resistant Organisms
por: Lu, Qiong, et al.
Publicado: (2021)

Efficacy and safety of polymyxin B in carbapenem-resistant gram-negative organisms infections
por: Xia, G. L., et al.
Publicado: (2021)

A Comparative Study of the Microbiological Efficacy of Polymyxin B on Different Carbapenem-Resistant Gram-Negative Bacteria Infections
por: Lu, Qiong, et al.
Publicado: (2021)

Analysis of cerebrospinal fluid protein concentrations of patients with cryptococcal meningitis treated with antifungal agents
por: Huang, Liang, et al.
Publicado: (2015)

Retrospective analysis of 1,641 cases of classic fever of unknown origin
por: Zhou, Guanyu, et al.
Publicado: (2020)

Treatment of Central Nervous System Infection Caused by Multidrug-Resistant Klebsiella pneumoniae with Colistin Sulfate Intravenously and Intrathecally: A Case Report
por: Lu, Xin, et al.
Publicado: (2022)

Comparison of clinical features and prognostic factors in HIV-negative adults with cryptococcal meningitis and tuberculous meningitis: a retrospective study
por: Qu, Junyan, et al.
Publicado: (2017)

Strongyloidiasis in a Patient Diagnosed by Metagenomic Next-Generation Sequencing: A Case Report
por: Qu, Junyan, et al.
Publicado: (2022)

Parenteral polymyxins: Assessing efficacy and safety in critically ill patients with renal dysfunction
por: Sekhri, Kavita, et al.
Publicado: (2013)

Polymyxin B Etest Fails to Distinguish Carbapenem-resistant Enterobacteriaceae with Elevated Polymyxin B MICs
por: Kulengowski, Brandon, et al.
Publicado: (2017)

Use of polymyxins for carbapenem-resistant infections in children and adolescents
por: Barco-Cabrera, Carolina, et al.
Publicado: (2022)

Polymyxin B-Based Regimens for Patients Infected with Carbapenem-Resistant Gram-Negative Bacteria: Clinical and Microbiological Efficacy, Mortality, and Safety
por: Qu, Jian, et al.
Publicado: (2022)

Optimization of polymyxin B regimens for the treatment of carbapenem-resistant organism nosocomial pneumonia: a real-world prospective study
por: Tang, Tiantian, et al.
Publicado: (2023)

Review and analysis of the overlapping threats of carbapenem and polymyxin resistant E. coli and Klebsiella in Africa
por: Venne, Danielle M., et al.
Publicado: (2023)

Delayed diagnosis of multiple systemic disseminated tuberculosis: A case report
por: Li, Huan, et al.
Publicado: (2022)

Clinical efficacy and safety of polymyxins based versus non-polymyxins based therapies in the infections caused by carbapenem-resistant Acinetobacter baumannii: a systematic review and meta-analysis
por: Lyu, Cheng, et al.
Publicado: (2020)

The Determination of Polymyxin B in Critically Ill Patients by the HPLC-MS/MS Method
por: Wang, Yirong, et al.
Publicado: (2023)

Population pharmacokinetic analysis and dosing optimization of polymyxin B in critically ill patients
por: Liang, Danhong, et al.
Publicado: (2023)

Polymyxin B Resistance in Carbapenem-Resistant Klebsiella pneumoniae, São Paulo, Brazil
por: Bartolleti, Flávia, et al.
Publicado: (2016)

Use of Carbapenems, Polymyxins, and Tigecycline in United States Children’s Hospitals, 2010–2014
por: Chiotos, Kathleen, et al.
Publicado: (2017)

Polymyxin for treatment of ventilator-associated pneumonia in a setting of high carbapenem resistance
por: Bento Talizin, Thalita, et al.
Publicado: (2020)

Efficacy and nephrotoxicity of polymyxin B in elderly patients with carbapenem resistant bacterial infection
por: Xia, G. L., et al.
Publicado: (2023)

Correlation between the drug concentration of polymyxin B and polymyxin B‐associated acute kidney injury in critically ill patients: A prospective study
por: Xu, Ying, et al.
Publicado: (2022)

Ceftazidime/Avibactam-Based Versus Polymyxin B-Based Therapeutic Regimens for the Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infection in Critically Ill Patients: A Retrospective Cohort Study
por: Zheng, Guanhao, et al.
Publicado: (2022)

Evaluation of procalcitonin, C-reactive protein, interleukin-6 & serum amyloid A as diagnostic biomarkers of bacterial infection in febrile patients
por: Qu, Junyan, et al.
Publicado: (2015)

Authors’ response
por: Qu, Junyan, et al.
Publicado: (2015)

In vitro and in vivo Activity of Combinations of Polymyxin B with Other Antimicrobials Against Carbapenem-Resistant Acinetobacter baumannii
por: Zhang, Hui, et al.
Publicado: (2021)

Polymyxin B-Associated Nephrotoxicity and Its Predictors: A Retrospective Study in Carbapenem-Resistant Gram-Negative Bacterial Infections
por: Wu, Xiao-Li, et al.
Publicado: (2022)

The Susceptibility of MDR-K. Pneumoniae To Polymyxin B Plus Its Nebulised Form Versus Polymyxin B Alone in Critically Ill South Asian Patients
por: Hasan, Md. Jahidul, et al.
Publicado: (2021)

Editorial: Multiple organ dysfunctions in perioperative critical illness and the prognosis after anesthesia
por: Liu, Ruixue, et al.
Publicado: (2023)

Combined effect of Polymyxin B and Tigecycline to overcome Heteroresistance in Carbapenem-Resistant Klebsiella pneumoniae
por: Tian, Yuan, et al.
Publicado: (2021)

Ceftazidime/Avibactam versus Polymyxin B in the Challenge of Carbapenem-Resistant Pseudomonas aeruginosa Infection
por: Chen, Juan, et al.
Publicado: (2022)

Combatting Planktonic and Biofilm Populations of Carbapenem-Resistant Acinetobacter baumannii with Polymyxin-Based Combinations
por: Wences, Marisol, et al.
Publicado: (2022)

Efficacy and safety of ceftazidime–avibactam versus polymyxins in the treatment of carbapenem-resistant Enterobacteriaceae infection: a systematic review and meta-analysis
por: Yang, Ping, et al.
Publicado: (2023)

The Response Measures to the Coronavirus Disease 2019 Outbreak in China
por: Qu, Junyan, et al.
Publicado: (2021)

Polymyxin B therapy based on therapeutic drug monitoring in carbapenem-resistant organisms sepsis: the PMB-CROS randomized clinical trial
por: Liu, Shaohua, et al.
Publicado: (2023)

Emergomyces orientalis Emergomycosis Diagnosed by Metagenomic Next-Generation Sequencing
por: He, Da, et al.
Publicado: (2021)

Endotoxin activity assay and polymyxin B hemoperfusion use in a cohort of critically ill patients
por: Cutuli, SL, et al.
Publicado: (2014)

2293. Revival of Polymyxins: A Single-Center Historical Cohort of Critically Ill Patients in Brazil
por: Maria Dantas de Maio Carrilho, Claudia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9jq83j4kbc8mcjdsss3khj5s2t